Jury rules Wyeth concealed Prempro breast-cancer risks. $3.7 million verdict.

Bloomberg News (10/24, Feeley, Pearson) reported, "A Pfizer Inc. unit concealed the breast-cancer risks of its hormone-replacement therapy drug Prempro and is liable for $3.7 million in damages to an Illinois woman," a jury ruled. The plaintiff "developed invasive breast cancer five years after she began taking Prempro, made by Pfizer's Wyeth unit," and the jury concluded that "Wyeth was at fault and is liable for the compensatory damages." Jurors stated that "Wyeth officials 'negligently failed to adequately warn'" the plaintiff's "doctors about Prempro's cancer risks and that failure played a role in the physician's decision to prescribe the drug."